This site is for informational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult your healthcare provider.
A Study Describing the Efficacy and Safety of Belimumab Administered in Adult Participants With Early Systemic Lupus Erythematosus (SLE) | MicrobiomeTrials
← Back to trials NCT06411249
A Study Describing the Efficacy and Safety of Belimumab Administered in Adult Participants With Early Systemic Lupus Erythematosus (SLE) Recruiting PHASE4 INTERVENTIONAL
Read the full scientific description See full eligibility requirements Trial Details Start: 2024-06-06Est. Completion: 2027-06-29
Enrollment target: 302 participantsLocations GSK Investigational Site, Anniston, Alabama, United States GSK Investigational Site, Flagstaff, Arizona, United States GSK Investigational Site, Mesa, Arizona, United States GSK Investigational Site, Tucson, Arizona, United States GSK Investigational Site, Covina, California, United States GSK Investigational Site, Fontana, California, United States GSK Investigational Site, Fullerton, California, United States GSK Investigational Site, Long Beach, California, United States GSK Investigational Site, Los Angeles, California, United States GSK Investigational Site, Mission Hills, California, United States GSK Investigational Site, San Diego, California, United States GSK Investigational Site, Temecula, California, United States GSK Investigational Site, Tujunga, California, United States GSK Investigational Site, Van Nuys, California, United States GSK Investigational Site, Van Nuys, California, United States GSK Investigational Site, Whittier, California, United States Other microbiome trials you might be interested in Antiphospholipid Syndrome (APS)
Antiphospholipid syndrome (APLS) is a rare pathology characterized by the association of thrombotic (arterial, venous) o…
Rouen, France Est. completion Oct 16, 2027
Autoimmune Diseases
Background:
Autoimmune diseases can be caused by genes people inherit from their parents. The gene changes that cause t…
Bethesda, United States Est. completion Apr 22, 2030
GSK Investigational Site, Aventura, Florida, United States
GSK Investigational Site, Clearwater, Florida, United States
GSK Investigational Site, Tamarac, Florida, United States
GSK Investigational Site, Tampa, Florida, United States
GSK Investigational Site, Atlanta, Georgia, United States
GSK Investigational Site, Morton Grove, Illinois, United States
GSK Investigational Site, Rockford, Illinois, United States
GSK Investigational Site, Baton Rouge, Louisiana, United States
GSK Investigational Site, New Orleans, Louisiana, United States
GSK Investigational Site, Detroit, Michigan, United States
GSK Investigational Site, Lansing, Michigan, United States
GSK Investigational Site, Brooklyn, New York, United States
GSK Investigational Site, Charlotte, North Carolina, United States
GSK Investigational Site, Winston-Salem, North Carolina, United States
GSK Investigational Site, Duncansville, Pennsylvania, United States
GSK Investigational Site, Austin, Texas, United States
GSK Investigational Site, Baytown, Texas, United States
GSK Investigational Site, Colleyville, Texas, United States
GSK Investigational Site, Fort Worth, Texas, United States
GSK Investigational Site, Houston, Texas, United States
GSK Investigational Site, Katy, Texas, United States
GSK Investigational Site, Plano, Texas, United States
GSK Investigational Site, Danville, Virginia, United States
GSK Investigational Site, Glendale, Wisconsin, United States
GSK Investigational Site, Berazategui, Argentina
GSK Investigational Site, Buenos Aires, Argentina
GSK Investigational Site, Buenos Aires, Argentina
GSK Investigational Site, Ciudad Autonoma Buenos Aires, Argentina
GSK Investigational Site, Ciudad Autonoma de Buenos Aire, Argentina
GSK Investigational Site, La Plata, Argentina
GSK Investigational Site, Mar del Plata, Argentina
GSK Investigational Site, Quilmes, Argentina
GSK Investigational Site, San Miguel de Tucumán, Argentina
GSK Investigational Site, Santa Fe, Argentina
GSK Investigational Site, Belo Horizonte, Minas Gerais, Brazil
GSK Investigational Site, São José do Rio Preto, São Paulo, Brazil
GSK Investigational Site, Cuiabá, Brazil
GSK Investigational Site, Juiz de Fora, Brazil
GSK Investigational Site, Passo Fundo, Brazil
GSK Investigational Site, Porto Alegre, Brazil
GSK Investigational Site, Porto Alegre, Brazil
GSK Investigational Site, Porto Alegre, Brazil
GSK Investigational Site, Salvador, Brazil
GSK Investigational Site, São Paulo, Brazil
GSK Investigational Site, São Paulo, Brazil
GSK Investigational Site, Angers, France
GSK Investigational Site, Saint-Priest-en-Jarez, France
GSK Investigational Site, Toulouse, France
GSK Investigational Site, Mainz, Rhineland-Palatinate, Germany
GSK Investigational Site, Herne, Germany
GSK Investigational Site, Lübeck, Germany
GSK Investigational Site, Mainz, Germany
GSK Investigational Site, Meerbusch, Germany
GSK Investigational Site, Athens, Greece
GSK Investigational Site, Athens, Greece
GSK Investigational Site, Athens, Greece
GSK Investigational Site, Heraklion, Greece
GSK Investigational Site, Thessaloniki, Greece
GSK Investigational Site, Brescia, Italy
GSK Investigational Site, Ferrara, Italy
GSK Investigational Site, Milan, Italy
GSK Investigational Site, Pisa, Italy
GSK Investigational Site, Reggio Emilia, Italy
GSK Investigational Site, Rome, Italy
GSK Investigational Site, Rozzano, Italy
GSK Investigational Site, Fukuoka, Japan
GSK Investigational Site, Miyagi, Japan
GSK Investigational Site, Osaka, Japan
GSK Investigational Site, Tokyo, Japan
GSK Investigational Site, Cuauhtémoc, Mexico City, Mexico
GSK Investigational Site, DF, Mexico
GSK Investigational Site, Guadalajara Jalisco, Mexico
GSK Investigational Site, León, Mexico
GSK Investigational Site, Mexico City, Mexico
GSK Investigational Site, Mexico City, Mexico
GSK Investigational Site, Mérida, Mexico
GSK Investigational Site, Monterrey Nuevo LeOn, Mexico
GSK Investigational Site, San Luis Potosí City, Mexico
GSK Investigational Site, Torreón, Mexico
GSK Investigational Site, Almada, Setúbal District, Portugal
GSK Investigational Site, Lisbon, Portugal
GSK Investigational Site, Porto, Portugal
GSK Investigational Site, Barcelona, Spain
GSK Investigational Site, Castellon, Spain
GSK Investigational Site, Córdoba, Spain
GSK Investigational Site, Murcia, Spain
GSK Investigational Site, Valladolid, Spain
GSK Investigational Site, VigoPontevedra, Spain